DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 03 · Volume 32 · May 1999 DOI: 10.1055/s-002-6186

Original Papers

  • 83
    Thomsen, K.; Schou, M.:

    Avoidance of Lithium Intoxication: Advice Based on Knowledge about the Renal Lithium Clearance under Various Circumstances

  • 87
    Bruijn, J. A.; Moleman, P.; Mulder, P. G. H.; van den Broek, W. W.:

    Depressed In-Patients Respond Differently to Imipramine and Mirtazapine

  • 93
    Ferszt, R.; Severus, E.; Bode, L.; Brehm, M.; Kühl, K.-P.; Berzewski, H.; Ludwig, H.:

    Activated Borna Disease Virus in Affective Disorders

  • 99
    Möller, H.-J.; Hampel, H.; Hegerl, U.; Schmitt, W.; Walter, K.:

    Double-Blind, Randomized, Placebo-Controlled Clinical Trial on the Efficacy and Tolerability of a Physostigmine Patch in Patients with Senile Dementia of the Alzheimer Type

  • 107
    Bonnet, U.; Banger, M.; Leweke, F. M.; Maschke, M.; Kowalski, T.; Gastpar, M.:

    Treatment of Alcohol Withdrawal Syndrome with Gabapentin

    • Case Report

  • 110
    Dettling, M.; Cascorbi, I.; Hellweg, R.; Deicke, U.; Weise, L.; Müller-Oerlinghausen, B.:

    Genetic Determinants of Drug-Induced Agranulocytosis: Potential Risk of Olanzapine?

  • 113
    Rohr, A.; Eichler, K.; Hafezi-Moghadam, N.:

    Citalopram, a Selective Serotonin Reuptake Inhibitor, Improves Symptoms of Friedreich's Ataxia

    • Letter to the Editor

  • 115
    Immich, H.:

    Papassotiropoulos et al., "The Risk of Acute Suicidality in Psychiatric In-Patients Increases with Low Plasma Cholesterol" (Pharmacopsychiatry 32 (1999) 1-4)